Biosynex SA ALBIO
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- €5.36
- Day Range
- €3.92–4.30
- 52-Week Range
- €3.92–11.00
- Bid/Ask
- €4.05 / €4.13
- Market Cap
- €44.33 Mil
- Volume/Avg
- 69,990 / 9,901
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.55
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- 4.42%
Company Profile
Biosynex SA is engaged in the research, development, and manufacturing of fast diagnosis tests on membrane support for health professionals. It manufactures and markets medical devices for screening, diagnosis.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 560
- Website
- http://www.biosynex.com
Comparables
Valuation
|
Metric
|
ALBIO
|
ALFRE
|
ARTO
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 1.82 | 59.21 |
Price/Book Value | 0.40 | 1.24 | 0.67 |
Price/Sales | 0.55 | 0.22 | 8.39 |
Price/Cash Flow | — | 8.82 | 105.86 |
Price/Earnings
ALBIO
ALFRE
ARTO
Financial Strength
|
Metric
|
ALBIO
|
ALFRE
|
ARTO
|
|---|---|---|---|
Quick Ratio | 0.74 | 1.20 | 7.02 |
Current Ratio | 1.32 | 1.21 | 7.38 |
Interest Coverage | −31.15 | 8.36 | 9.37 |
Quick Ratio
ALBIO
ALFRE
ARTO
Profitability
|
Metric
|
ALBIO
|
ALFRE
|
ARTO
|
|---|---|---|---|
Return on Assets (Normalized) | −11.07% | 3.82% | 0.93% |
Return on Equity (Normalized) | −18.22% | 12.87% | 0.99% |
Return on Invested Capital (Normalized) | −13.23% | 8.02% | 0.47% |
Return on Assets
ALBIO
ALFRE
ARTO
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Pryxhwxlb | Tddfxk | $185.5 Bil | |
SYK
| Stryker Corp | Qhlnbyss | Yskvd | $128.2 Bil | |
MDT
| Medtronic PLC | Gtlcdsqm | Qjyprwx | $106.7 Bil | |
BSX
| Boston Scientific Corp | Zwgcxwks | Wybvxg | $99.0 Bil | |
DXCM
| DexCom Inc | Fshzdhhcs | Hyvr | $53.1 Bil | |
EW
| Edwards Lifesciences Corp | Bqshrgsx | Rmxfmnw | $52.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Gdbxmdxzk | Chyj | $24.9 Bil | |
ALGN
| Align Technology Inc | Pfysnnsg | Bqrgfl | $23.5 Bil | |
PHG
| Koninklijke Philips NV ADR | Ybfglbsjd | Xtsbqz | $18.9 Bil | |
PODD
| Insulet Corp | Jnlkgthwn | Jbgkts | $11.7 Bil |